Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
TORL BioTherapeutics is a clinical-stage biopharmaceutical business.
Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.
Wrench Group offers home repair, replacement and maintenance services specializing in heating and ventilation.
Celcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.
Juniper Square provides software and fund administration services that streamline collaboration and communication between GPs and LPs.
MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.
Madrigal Pharmaceuticals is a biopharmaceutical company developing therapeutics for the treatment of cardiovascular-metabolic diseases.
Crusoe AI Data Center is a joint venture of Crusoe, Blue Owl Capital and Primary Digital Infrastructure.
Latigo Biotherapeutics is a clinical-stage biotechnology company that develops novel, non-opioid therapies for chronic pain.
Perk is the intelligent platform for travel and spend.
Windward Bio develops monoclonal antibodies for advanced immunological diseases.
Clinical stage biotechnology company developing restorative treatments for people affected by neuropsychiatric & neuroimmunologic disorders
Cardurion is a cardiovascular biotechnology company developing therapeutics for the treatment of heart failure and cardiovascular diseases.
Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras.
Context Therapeutics is a clinical-stage biopharmaceutical company.
Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.
Alterome Therapeutics is a biopharmaceutical company developing alteration-specific targeted therapies.
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
Finastra provides the broadest portfolio of financial services software.
6sense is an account-based marketing platform that helps B2B organizations achieve predictable revenue growth.
Coherent is a software-as-a-service company for insurance companies.
QuVa Pharma is a quality-compliant manufacturer of compounded and ready-to-administer sterile injectable products.
Blue Owl has invested in 70 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Blue Owl's top investment sectors include Biotechnology, Health Care, Medical, Biopharma, Pharmaceutical. The firm invests across 35 different industry categories.
Among tracked funding rounds, Crusoe AI Data Center received $11.6B in a Undisclosed round. Blue Owl's total known invested capital is $35.7B.
Blue Owl's average investment size is $517.6M across its portfolio of 70 companies.
Recent Blue Owl portfolio additions include TORL BioTherapeutics, Star Therapeutics, Wrench Group, Celcuity, Juniper Square. These companies were founded in 2020 or later.